Coronavirus immunity: From T cells to B cells

Advances in Experimental Medicine and Biology

Volumn 581, Issue , 2006, Pages 341-349

  Bergmann, Cornelia C ^a   Tschen, S I ^a   Ramakrishna, Chandran ^a   Gonzales, J M ^a   Stohlman, Stephan A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84934444008     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-33012-9_61     Document Type: Conference Paper

References (62)

1. Z. Fabry, C. S. Raine, and M. N. Hart, Nervous tissue as an immune compartment: the dialect of the immune response in the CNS, Immunol. Today 15, 218-224 (1994).
2. W. F. Hickey, Basic principles of immunological surveillance of the normal central nervous system, Glia 36, 118-124 (2001).
3. R. Dorries, The role of T-cell-mediated mechanisms in virus infections of the nervous system, Curr. Top. Microbiol. Immunol. 253, 219-245 (2001).
4. D. E. Griffin, Immune responses to RNA-virus infections of the CNS, Nat. Rev. Immunol. 3, 493-502 (2003).
5. R. M. Ransohoff, P. Kivisakk, and G. Kidd, Three or more routes for leukocyte migration into the central nervous system, Nat. Rev. Immunol. 3, 569-581 (2003).
6. S. Stohlman, C. Bergmann, and S. Perlman, in: Persistent Viral Infection, edited by R. Ahmed and I. Chen (John Wiley, New York, 1999), pp. 537-558.
7. N. W. Marten, S. A. Stohlman, and C. C. Bergmann, MHV infection of the CNS: mechanisms of immune-mediated control, Viral Immunol. 14, 1-18 (2001).
8. M. J. Buchmeier and T. E. Lane, Viral-induced neurodegenerative disease, Curr. Opin. Microbiol. 2, 398-402 (1999).
9. M. T. Lin, D. R. Hinton, N. W. Marten, C. C. Bergmann, and S. A. Stohlman, Antibody prevents virus reactivation within the central nervous system, J. Immunol. 162, 7358-7368 (1999).
10. C. Ramakrishna, S. A. Stohlman, R. Atkinson, M. Schlomchik, and C. C. Bergmann, Mechanisms of central nervous system viral persistence: critical role of antibody and B cells, J. Immunol. 168, 1204-1211 (2002).
11. J. O. Fleming, M. Trousdale, F. El-Zaatari, S. A. Stohlman, and L. P. Weiner, Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies, J. Virol. 58, 869-875 (1986).
12. T. E. Lane, V. C. Asensio, N. Yu,. A. D., Paoletti, I. L.Campbell, and M. J. Buchmeier, Dynamic regulation of alpha- and beta-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease, J. Immunol. 160, 970-978 (1998).
13. B. Parra, D. R. Hinton, M. T. Lin, D. J. Cua, and S. A. Stohlman, Kinetics of cytokine mRNA expression in the CNS following lethal and sublethal coronavirus-induced encephalomyelitis, Virology 233, 260-270 (1997).
14. B. D. Pearce, M. V. Hobbs, T. S. McGraw, and M. J. Buchmeier, Cytokine induction during T-cell-mediated clearance of mouse hepatitis virus from neurons in vivo, J. Virol. 68, 5483-5495 (1994).
15. J. D. Rempel, S. J. Murray, J. Meisner, and M. J. Buchmeier, Differential regulation of innate and adaptive immune responses in viral encephalitis, Virology 318, 381-392 (2004).
16. J. D. Rempel, L. A. Quina, P. K. Blakelu-Gonzales, M. J. Buchmeier, and D. L. Gruol, Viral induction of central nervous system innate immune responses, J. Virol. 79, 4369-4381 (2005).
17. T. E. Lane and M. J. Buchmeier, in: Universes in Delicate Balance: Chemokines and the Nervous System, edited by R. Ransohoff, et al. (Elsevier Press, New York, 2002), pp. 191-202.
18. J. Zhou, S. Stohlman, R. Atkinson, D. Hinton, and N. Marten, Matrix metalloproteinase expression correlates with virulence following neurotropic mouse hepatitis virus infection, J. Virol. 76, 7373-7384 (2002).
19. V. W. Yong, C. Power, P. Forsyth, and D. R. Edwards, Metalloproteinases in biology and pathology of the nervous system, Nature 2, 502-511 (2001).
20. J. Zhou, S. Stohlman, D. R. Hinton, and N. Marten, Neutrophils modulate inflammation during viral induced encephalitis, J. Immunol. 170, 3331-3336 (2003).
21. C. C. Bergmann, B. Parra, D. Hinton, C. Ramakrishna, M. Morrison, and S. A. Stohlman, Perforin mediated effector function within the CNS requires IFN-γ mediated MHC upregulation, J. Immunol. 170, 3204-3213 (2003).
22. J. Zhou, N. W. Marten, C. C. Bergmann, W. B. Macklin, D. R. Hinton, and S. A. Stohlman, Expression of matrix metalloproteinases and their tissue inhibitor during viral encephalitis, J. Virol. 79, 4764-4773 (2005).
23. +-T-cell effector function and migration following viral infection, J. Virol. 77, 4004-4014 (2003).
24. M. J. Trifilo, C. Montalto-Morrison, L. N. Stiles, K. R. Hurst, J. L. Hardison, J. E. Manning, P. S. Masters, and T. E. Lane, CXC chemokine ligand 10 controls viral infection in the central nervous system: Evidence for a role in innate immune response through recruitment and activation of natural killer cells, J. Virol. 78, 585-594 (2004).
25. M. J. Trifilo and T. E. Lane, The CC chemokine ligand 3 regulates CD11c+CD11b+CD8alpha-dendritic cell maturation and activation following viral infection of the central nervous system: implications or a role in T cell activation, Virology 327, 8-15 (2004).
26. T. E. Lane, M. T. Liu, B. P. Chen, V. C. Asensio, R. M. Samawi, A. D. Paoletti, I. L. Campbell, S. L. Kunkel, H. S. Fox, and M. J. Buchmeier, A central role for CD4(+) T cells and RANTES in virus-induced central nervous system inflammation and demyelination, J. Virol. 74, 1415-1424 (2000).
27. W. G. Glass, M. J. Hickey, J. L. Hardison, M. T. Liu, J. E. Manning, and T. E. Lane. Antibody targeting of the CC chemokine ligand 5 (CCL5) results in diminished leukocyte infiltration into the central nervous system and reduced neurologic disease in a viral model of multiple sclerosis, J. Immunol. 172, 4018-4025 (2004).
28. S. A. Stohlman, D. R. Hinton, D. Cua, E. Dimacali, J. Sensintaffar, S. Tahara, F. Hofman, and Q. Yao, Tumor necrosis factor expression during mouse hepatitis virus induced demyelination, J. Virol. 69, 5898-5903 (1995).
29. L. Pewe and S. Perlman, Cutting edge: CD8 T cell-mediated demyelination is IFN-gamma dependent in mice infected with a neurotropic coronavirus, J. Immunol. 168, 1547-1551 (2002).
30. C. C. Bergmann, J. Altman, D. Hinton, and S. A. Stohlman, Inverted immunodominance and Impaired cytolytic function of CD8+ T cells during viral persistence in the CNS, J. Immunol. 163, 3379-3387 (1999).
31. N. Marten, S. A. Stohlman, Z. Zhou, and C. C. Bergmann, Kinetics of virus specific CD8+ T cell expansion and trafficking following central nervous system infection, J. Virol. 77, 2775-2778 (2003).
32. F. I. Wang, D. R. Hinton, W. Gilmore, M. D. Trousdale, and J. O. Fleming, Sequential infection of glial cells by the murine hepatitis virus JHM strain (MHV-4) leads to a characteristic distribution of demyelination, Lab. Invest. 66, 744-754 (1992).
33. M. T. Liu, B. P. Chen, P. Oertel , M. J. Buchmeier, D. Armstrong , T. A. Hamilton, and T. E. Lane, The T cell chemoattractant IFN-inducible protein 10 (IP-10) is essential in host defense against viral-induced neurologic disease, J. Immunol. 165, 2327-2330 (2000).
34. M. T. Liu, H. S. Keirstead, and T. E. Lane, Naturalization of the chemokine CXCL10 reduces inflammatory cell invasion and demyelination and improves neurological function in a viral model of multiple sclerosis, J. Immunol. 167, 4091-4097 (2001).
35. A. E. Hauser, G. F. Debes, S. Arce, G. Cassese, A. Hamann, A. Radbruch, and R. A. Manz, Chemotactic responsiveness toward ligands for CXCR3 and CXCR4 is regulated on plasma blasts during the time course of a memory immune response, J. Immunol. 169, 1277-1282 (2002).
36. C. C. Bergmann, B. Parra, D. R. Hinton, C. Ramakrishna, K. C. Dowdell, and S. Stohlman, Perforin and interferon gamma mediated control of coronavirus central nervous system infection by CD8 T cells in the absence of CD4 T cells, J. Virol. 78, 1739-1750 (2004).
37. S. A. Stohlman, C. C. Bergmann, M. T. Lin, D. J. Cua, and D. R. Hinton, CTL effector function within the CNS requires CD4+ T cells, J. Immunol. 160, 2896-2904 (1998).
38. J. Zhou, D. R. Hinton, S. A. Stohlman, and N. Marten, Maintenance of CD8+ T cells during acute viral infection of the central nervous system requires CD4+ T cells but not interleukin-2, Virol. Immunol. 18, 162-169 (2005).
39. A. M. Chen, N. Khanna, S. A. Stohlman, and C. C. Bergmann, Virus-specific and bystander CD8 T cells recruited during virus-induced encephalomyelitis, J. Virol. 79, 4700-4708 (2005).
40. N. Marten, S. Stohlman, and C. C. Bergmann, Role of Viral Persistence in Retaining CD8+ T cells within the central nervous system, J. Virol. 74, 7903-7910 (2000).
41. N. W. Marten, S. A. Stohlman, R. Atkinson, D. A. Hinton, and C. C. Bergmann, Contributions of CD8+ T cells and viral spread to demyelinating disease, J. Immunol. 164, 4080-4088 (2000).
42. M. Lin, S. Stohlman, and D. Hinton, Mouse hepatitis virus is cleared from the central nervous system of mice lacking perforin-mediated cytolysis, J. Virol. 71, 383-391 (1997).
43. B. Parra, D. R. Hinton, N. Marten, C. C. Bergmann, M. Lin, C. Yang, and S. A. Stohlman, Gamma interferon is required for viral clearance from central nervous system oligodendroglia, J. Immunol. 162, 1641-1647 (1999).
44. B. Parra, M. Lin, S. Stohlman, C. Bergmann, R. Atkinson, and D. Hinton, Contributions of Fas-Fas ligand interactions to the pathogenesis of mouse hepatitis virus in the central nervous system, J. Virol. 74, 2447-2450 (2000).
45. J. M. Gonzalez, C. C. Bergmann, B. Fuss, D. R. Hinton, W. B. Macklin, and S. A. Stohlman, Expression of a dominant negative IFN-γ receptor on mouse oligodendrocytes, Glia 51, 22-34 (2005).
46. J. M. Redwine, M. J. Buchmeier, and C. F. Evans, In vivo expression of major histocompatibility complex molecules on oligodendrocytes and neurons during viral infection, Am. J. Pathol. 159, 1219-1224 (2001).
47. C. Ramakrishna, S. Stohlman, R. Atkinson, D. H. Hinton, and C. C. Bergmann, Differential regulation of primary and secondary CD8+ T cells in the CNS, J. Immunol. 173, 6265-6273 (2004).
48. S. Hawke, P. G. Stevenson, S. Freeman, and C. R. M. Bangham, Long term persistence of activated cytotoxic T lymphocytes after viral infection of the central nervous system, J. Exp. Med. 187, 1575-1582 (1998).
49. N. Marten, S. Stohlman, W. Smith-Begolka, S. Miller, M. Dimicali, Q. Yao, S. Stohl, J. Goverman, and C. Bergmann, Selection of CD8+ T cells with highly focused specificity during viral persistence in the central nervous system, J. Immunol. 162, 3905-3914 (1999).
50. D. Masopust and R. Ahmed, Reflections on CD8 T-cell activation and memory, Immunol. Res. 29, 151-160 (2004).
51. L. Lefrancois and D. Masopust, T cell immunity in lymphoid and non-lymphoid tissues, Curr. Opin. Immunol. 14, 503-508 (2002).
52. A. E. Matthews, S. R. Weiss, M. J. Shlomchik, L. G. Hannum, J. L. Gombold, and J. Y. Paterson, Antibody is required for clearance of infectious murine hepatitis virus A59 from the central nervous system, but not the liver, J. Immunol. 167, 5254-5263 (2001).
53. C. Ramakrishna, C. Bergmann, R. Atkinson, and S. Stohlman, Control of central nervous system viral persistence by neutralizing antibody, J. Virol. 77, 4670-4678 (2003).
54. S. I. Tschen, C. Bergmann, C. Ramakrishna, R. Atkinson, and S. Stohlman, Recruitment kinetics of antibody secreting cells within the CNS following viral encephalomyelitis, J. Immunol. 168, 2922-2929 (2002).
55. G. F. Wu, A. A. Dandekar, L. Pewe, and S. Perlman, CD4 and CD8 T cells have redundant but not identical roles in virus-induced demyelination, J. Immunol. 165, 2278-2286 (2000).
56. G. F. Wu, L. Pewe, and S. Perlman, Coronavirus-induced demyelination occurs in the absence of inducible nitric oxide synthase, J. Virol. 74, 7683-7686 (2000).
57. L. Pewe, J. Haring, and S. Perlman, CD4 T-cell-mediated demyelination is increased in the absence of gamma interferon in mice infected with mouse hepatitis virus, J. Virol. 76, 7329-7333 (2002).
58. A. A. Dandekar, K. O'Malley, and S. Perlman, Important roles for gamma interferon and NKG2D in gammadelta T-cell-induced demyelination in T-cell receptor beta-deficient mice infected with a coronavirus, J. Virol. 79, 9388-9396 (2005).
59. T. S. Kim and S. Perlman, Viral expression of CCL2 is sufficient to induce demyelination in RAG1-/- mice infected with a neurotropic coronavirus, J. Virol. 79, 7113-7120 (2005).
60. + T cell-mediated demyelination after viral infection of the central nervous system, J. Immunol. 169, 1550-1555 (2002).
61. J. Cabarrocas, J. Bauer, E. Piaggio, R. Liblau, and H. Lassman, Effective and selective immune surveillance of the brain by MHC class I-restricted cytotoxic T lymphocytes, Eur. J. Immunol. 33, 1174-1182 (2003).
62. D. B. McGavern and P. Truong, Rebuilding an immune-mediated central nervous system disease: weighing the pathogenicity of antigen-specific versus bystander T cells, J. Immunol. 173, 4779-4790 (2004).